Adam C. Ehrlich, MD, MPH, Interim Chief of the Section of Gastroenterology and Hepatology at the Lewis Katz School of Medicine at Temple University and Medical Director of the Inflammatory Bowel Disease (IBD) Program at Temple University Hospital, provided perspective to HealthCentral on a new Gastroenterology paper that makes the case for de-intensifying therapy for people with IBD.
Weather Alert: Following the winter storm, all Temple Health hospitals, campuses and clinical locations remain open. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org or FoxChase.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH